A Vienna-based MedTech startup developing the GoldenSite platform for site-specific protein conjugation, with a lead antibody-drug conjugate program for metastatic triple-negative breast cancer.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €3 M | Mar, 2026 | series-c |
Industries
Frequently Asked Questions
Where is VALANX Biotech located?
VALANX Biotech is located in Vienna, Austria.
What industries does VALANX Biotech operate in?
VALANX Biotech operates in the following industries: MedTech, Biotechnology, Oncology, Drug Development.
How much total funding has VALANX Biotech raised?
VALANX Biotech has raised a total of $3,000,000.
Who are the investors in VALANX Biotech?
The investors in VALANX Biotech are: Foundation Fournier-Majoie, FUJIFILM Corporation, Xista Science Ventures, tecnet equity, Urs Spitz, SkyGene.
Who are the founders of VALANX Biotech?
The founders of VALANX Biotech are: Michael Lukesch, Georg Altenbacher.